LSI USA '23 filling fast. Register Now

NuPathe (NASDAQ: PATH) (Acquired)

Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkin...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NuPathe (NASDAQ: PATH) (Acquired) plus 5403 other startups.

Start Free 7 Day Trial Now

Learn More About NuPathe (NASDAQ: PATH) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Our Clients